Lancaster, J. J.
Grijalva, A.
Fink, J.
Ref, J. http://orcid.org/0000-0002-7381-2099
Daugherty, S.
Whitman, S.
Fox, K.
Gorman, G.
Lancaster, L. D.
Avery, R.
Acharya, T.
McArthur, A.
Strom, J.
Pierce, M. K.
Moukabary, T.
Borgstrom, M.
Benson, D.
Mangiola, M.
Pandey, A. C. http://orcid.org/0000-0002-1541-7023
Zile, M. R.
Bradshaw, A.
Koevary, J. W.
Goldman, S.
Funding for this research was provided by:
ADHS | Arizona Biomedical Research Commission
Article History
Received: 7 February 2023
Accepted: 9 November 2023
First Online: 25 November 2023
Competing interests
: Drs. Goldman, Koevary, Lancaster and Ms. Sherry Daugherty have disclosed a financial interest in Avery Therapeutics, Inc. to the University of Arizona. In addition, the University of Arizona has a financial interest in Avery Therapeutics, Inc. These interests have been reviewed and are being managed by the University of Arizona in accordance with its policies on outside interests. The work outlined in this report were the basis of forming a commercial entity, Avery Therapeutics. Drs. Goldman, Koevary, Lancaster and Ms. Sherry Daugherty have disclosed a financial interest in Avery Therapeutics, Inc. to the University of Arizona. In addition, the University of Arizona has a financial interest in Avery Therapeutics, Inc. These interests have been reviewed and are being managed by the University of Arizona in accordance with its policies on outside interests. All other authors declare no competing interests.